Novartis’ Beovu recommended by NICE

Pharma Times

28 July 2022 - Patients set to benefit from new treatment for sight-threatening eye condition

Thousands of people could receive transformational treatment after a new option for diabetic macular oedema was recommended by NICE.

Read Pharma Times article

Michael Wonder

Posted by:

Michael Wonder